Generation of a Novel MMTV-tTA Transgenic Mouse Strain for the Targeted Expression of Genes in the Embryonic and Postnatal Mammary Gland

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Sakamoto, Kazuhito ^a   Schmidt, Jeffrey W ^a   Wagner, Kay Uwe ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GREEN FLUORESCENT PROTEIN; TETRACYCLINE REGULATIBLE TRANSACTIVATOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL CELL; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; LONG TERMINAL REPEAT; MOUSE; MULTIPOTENT STEM CELL; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; SALIVARY GLAND; STEM CELL; TRANSACTIVATION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CELL LINE; EMBRYO, MAMMALIAN; EPITHELIAL CELLS; FEMALE; GENE DELETION; GENE EXPRESSION; GENES, ERBB-2; INTEGRASES; LIGANDS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; TERMINAL REPEAT SEQUENCES; TETRACYCLINE; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

EID: 84865626916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043778     Document Type: Article

References (27)

1. Furth PA, St OL, Boger H, Gruss P, Gossen M, et al. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A 91: 9302-9306.
2. Hennighausen L, Wall RJ, Tillmann U, Li M, Furth PA, (1995) Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J Cell Biochem 59: 463-472.
3. Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, et al. (2002) A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J 16: 283-292.
4. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P, (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105-115.
5. Creamer BA, Triplett AA, Wagner KU, (2009) Longitudinal analysis of mammogenesis using a novel tetracycline-inducible mouse model and in vivo imaging. Genesis 47: 234-245.
6. Creamer BA, Sakamoto K, Schmidt JW, Triplett AA, Moriggl R, et al. (2010) Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol 30: 2957-2970.
7. Zhang Q, Triplett AA, Harms DW, Lin WC, Creamer BA, et al. (2010) Temporally and spatially controlled expression of transgenes in embryonic and adult tissues. Transgenic Res 19: 499-509.
8. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, et al. (2004) Defining the Epithelial Stem Cell Niche in Skin. Science 303: 359-363.
9. Challen GA, Goodell MA, (2008) Promiscuous expression of H2B-GFP transgene in hematopoietic stem cells. PLoS One 3: e2357.
10. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, et al. (2011) Distinct stem cells contribute to mammary gland development and maintenance. Nature 479: 189-193.
11. Kawamoto S, Niwa H, Tashiro F, Sano S, Kondoh G, et al. (2000) A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Letters 470: 263-268.
12. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, et al. (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A 89: 10578-10582.
13. Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU, (2004) Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 23: 6980-6985.
14. Triplett AA, Montagna C, Wagner KU, (2008) A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis. Neoplasia 10: 1325-1334.
15. Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, et al. (2002) Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell 2: 451-461.
16. Gunther EJ, Moody SE, Belka GK, Hahn KT, Innocent N, et al. (2003) Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev 17: 488-501.
17. Boxer RB, Jang JW, Sintasath L, Chodosh LA, (2004) Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 6: 577-586.
18. Zeng X, Shaikh FY, Harrison MK, Adon AM, Trimboli AJ, et al. (2010) The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene 29: 5103-5112.
19. Iavnilovitch E, Cardiff RD, Groner B, Barash I, (2004) Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice. Int J Cancer 112: 607-619.
20. Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, et al. (2003) Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22: 4664-4674.
21. Parmar H, Cunha GR, (2004) Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocr Relat Cancer 11: 437-458.
22. Robinson GW, (2007) Cooperation of signalling pathways in embryonic mammary gland development. Nat Rev Genet 8: 963-972.
23. Sakakura T, Nishizuka Y, Dawe CJ, (1979) Capacity of mammary fat pads of adult C3H/HeMs mice to interact morphogenetically with fetal mammary epithelium. J Natl Cancer Inst 63: 733-736.
24. Spike BT, Engle DD, Lin JC, Cheung SK, La J, et al. (2012) A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell 10: 183-197.
25. Kordon EC, Smith GH, (1998) An entire functional mammary gland may comprise the progeny from a single cell. Development 125: 1921-1930.
26. Wagner KU, Young WS, Liu X, Ginns EI, Li M, et al. (1997) Oxytocin and milk removal are required for post-partum mammary-gland development. Genes Funct 1: 233-244.
27. Matulka LA, Triplett AA, Wagner KU, (2007) Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells. Dev Biol 303: 29-44.